Evoke Pharma Price to Free Cash Flow Ratio 2012-2024 | EVOK

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

PE Ratio P/S Ratio Price/Book Ratio Price-FCF Ratio Net Worth

Evoke Pharma price to free cash flow ratio from 2012 to 2024. Price to free cash flow ratio can be defined as

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

PE Ratio P/S Ratio Price/Book Ratio Price-FCF Ratio Net Worth

Evoke Pharma price to free cash flow ratio from 2012 to 2024. Price to free cash flow ratio can be defined as

Related Stocks
Company Name	Market Cap
Teva Pharmaceutical Industries (TEVA)	$24.9B
Dr Reddy's Laboratories (RDY)	$12.6B
BridgeBio Pharma (BBIO)	$6.8B
Bausch Health Cos (BHC)	$2.8B
Supernus Pharmaceuticals (SUPN)	$2.1B
Amphastar Pharmaceuticals (AMPH)	$1.7B
Personalis (PSNL)	$396M
Taysha Gene Therapies (TSHA)	$314M
Assembly Biosciences (ASMB)	$95M
Sol-Gel Technologies (SLGL)	$25M
Teligent (TLGT)	$0M